SARAH LOUDERMILK: Open Payments
NPI 1295156917 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 94 payments from 10 companies in 2025. Trend: 2023 $2,369 · 2024 $2,288 · 2025 $1,879
Food & beverage: $1,695Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $606 |
| Janssen Biotech, Inc. | 23 | $549 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $223 |
| Ferring Pharmaceuticals Inc. | 4 | $105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $99 |
| Aimmune Therapeutics, Inc. | 5 | $98 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Braintree Laboratories, Inc. | 1 | $24 |
| VIVUS LLC | 1 | $17 |
Products named: TREMFYA, RINVOQ, ENTYVIO, LINZESS, SKYRIZI, REBYOTA, ZENPEP, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
